Replies to post #428757 on Anavex Life Sciences Corp (AVXL)

[abew4me]

That's up to the Anavex team to decide whether or not they want to conduct a separate P2 trial for dosage.

IMO, they have enough data with all of the P1s, P2s, and P3 trials (which includes pediatric and adults) to determine dosages for most every age group.

The question is whether those dosages can be applied to other diseases? IMO, yes.